Ding Ma
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 16
- Cancer, Hypoxia, and Metabolism 13
- MicroRNA in disease regulation 12
- Oncology 58
- Cancer Cells and Metastasis 12
- Co-authors
- Jianfeng Zhou (66 shared papers)Qinglei Gao (51 shared papers)Zheng Hu (10 shared papers)Shixuan Wang (36 shared papers)Gang Xu (28 shared papers)Gang Chen (27 shared papers)Song‐Yang Wu (3 shared papers)Yi‐Zhou Jiang (4 shared papers)
- Journals
- Cancer Letters (14 papers)Oncotarget (13 papers)PLoS ONE (11 papers)Gynecologic Oncology (9 papers)Frontiers of Medicine (7 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ding Ma
260 papers receiving 8.1k citations
Ding Ma's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 1.6k
- Oncology 1.9k
- Immunology 1.2k
- Obstetrics and Gynecology 394
- Molecular Biology 3.6k
Countries citing papers authored by Ding Ma
This map shows the geographic impact of Ding Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Ma more than expected).
Fields of papers citing papers by Ding Ma
This network shows the impact of papers produced by Ding Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Ma. The network helps show where Ding Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 262 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human papillomavirus vaccine against cervical cancer: Opportunity and challenge Hit paper breakdown → | 2019 | 352 |
| 2 | Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response Hit paper breakdown → | 2021 | 343 |
| 3 | 2018 | 255 | |
| 4 | Comprehensive metabolomics expands precision medicine for triple-negative breast cancer Hit paper breakdown → | 2022 | 247 |
| 5 | 2007 | 193 | |
| 6 | 2011 | 180 | |
| 7 | 2010 | 136 | |
| 8 | 2017 | 129 | |
| 9 | Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study Hit paper breakdown → | 2022 | 126 |
| 10 | 2019 | 119 | |
| 11 | 2013 | 117 | |
| 12 | 2007 | 106 | |
| 13 | 2014 | 104 | |
| 14 | 2008 | 102 | |
| 15 | 2022 | 100 | |
| 16 | 2018 | 99 | |
| 17 | 2009 | 96 | |
| 18 | 2018 | 90 | |
| 19 | 2016 | 90 | |
| 20 | 2017 | 87 |
About Ding Ma
Ding Ma is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Epidemiology, having authored 262 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (28 papers), Virus-based gene therapy research (21 papers), Cancer-related molecular mechanisms research (16 papers), Endometrial and Cervical Cancer Treatments (13 papers), Cancer, Hypoxia, and Metabolism (13 papers), Cancer Cells and Metastasis (12 papers), MicroRNA in disease regulation (12 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.9k citations), Immunology (1.2k citations), Obstetrics and Gynecology (394 citations) and Molecular Biology (3.6k citations). Ding Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jianfeng Zhou, Qinglei Gao, Zheng Hu, Shixuan Wang, Gang Xu, Gang Chen, Song‐Yang Wu, Yi‐Zhou Jiang, Shujie Liao and Yi Xiao. Their work appears in journals such as Cancer Letters, Oncotarget, PLoS ONE, Gynecologic Oncology and Frontiers of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.